The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryu, H.
Right arrow Articles by Chung, H.-T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryu, H.
Right arrow Articles by Chung, H.-T.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
*Genetics Home Reference
Hazardous Substances DB
*L-TYROSINE
The Journal of Immunology, 2000, 165: 2116-2123.
Copyright © 00 by The American Association of Immunologists

Regulation of Neutrophil Adhesion by Pituitary Growth Hormone Accompanies Tyrosine Phosphorylation of Jak2, p125FAK, and Paxillin1

Hoon Ryu2,3,*,§, Jung-Hee Lee2,*,{ddagger}, Kwon Seop Kim{dagger}, Seong-Min Jeong§, Pyeung-Hyeun Kim{ddagger} and Hun-Taeg Chung4,¶

* Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and {dagger} Department of Cell Biology, Harvard Medical School, Boston, MA 02115; {ddagger} Department of Microbiology, Kangwon National University College of Natural Science, Chunchon, Kangwon, Republic of Korea; and § Department of Immunology and Bioenergy (Qi) Medicine, Institute of Biotechnology, and Department of Microbiology and Immunology, Wonkwang University School of Medicine, Iksan, Chonbuk, Republic of Korea


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Neutrophil adhesion is fundamentally important during the onset of inflammatory responses. The adhesion signaling pathways control neutrophil arrest and extravasation and influence neutrophil shape and function at sites of inflammation. In the present study the intracellular signaling pathways for the adhesion of human neutrophils by pituitary growth hormone (GH) were examined. Pituitary GH triggered the tyrosine phosphorylation of Janus kinase 2 (Jak2) and STAT3 in neutrophils. In addition, pituitary GH treatment resulted in the morphological changes and the tyrosine phosphorylation of focal adhesion kinase (p125FAK) and paxillin. Preincubation with genistein, a tyrosine kinase inhibitor, blocked the GH-stimulated adhesion and Jak2, STAT3, p125FAK, and paxillin phosphorylation. Confocal microscopy revealed that pituitary GH stimulates the focal localization of p125FAK, paxillin, phosphotyrosine, and filamentous actin filament into the membrane rufflings and uropods of human neutrophils. Immunoprecipitation experiments revealed a physical association of Jak2 with p125FAK via STAT3 in vivo. Also an in vitro kinase assay showed an augmentation of p125FAK autophosphorylation as a result of pituitary GH treatment. These results suggest that pituitary GH modulates neutrophil adhesion through tyrosine phosphorylation of Jak2, p125FAK, and paxillin and actin polymerization.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Neutrophils are the primary effector cells in acute inflammation (1). They are rapidly recruited in large numbers from the bloodstream by processes of adhesion to vascular endothelium, transendothelial migration, and chemotaxis to a local inflammatory site (2, 3). In the presence of inflammatory mediators such as chemotactic agonists and cytokines (4), neutrophils interacting with plasma and extracellular matrix proteins (3, 5, 6) or endothelial counter-receptors reorganize their cytoskeleton and spread over the adhesive surface (7, 8), diapedese, produce reactive oxygen intermediates, and release granule constituents (9, 10, 11, 12, 13).

Pituitary growth hormone (GH)5 plays diverse roles in the promotion of cell growth and metabolism (14). GH has been shown to influence the development of the immune organ and the function of immune cells (15, 16, 17, 18, 19). The binding of GH to its receptor causes dimerization of two growth hormone receptor (GHR), which, in turn, initiates the signal transduction in the cell. Lacking intrinsic tyrosine kinase activity, the GHR recruits and activates a member of the Janus family of cytosolic kinases (JAKs) upon dimerization (20, 21). In addition to the GHR and itself, Jak2 phosphorylates STATs (22, 23). We and others have previously demonstrated that recombinant GH (rGH) primes and enhances respiratory burst function in human neutrophils through intracellular calcium increase (12, 24, 25, 26, 27, 28, 29, 30). Although GH-induced priming of neutrophils is accompanied by an increase in adhesion (16), the molecular mechanisms by which GH activates neutrophil adhesion have not been determined. Therefore, an interesting question in the operation of GH in neutrophil adhesion is how the signal is transduced from stimuli to the adhesion.

Focal adhesion kinase (p125FAK) is a cytosolic kinase that is concentrated in focal contacts (31, 32). Because of its localization, p125FAK has been thought to be involved in regulating cell morphology and cell migration in response to cell adhesion to extracellular matrix proteins (31, 33). p125FAK is rapidly phosphorylated following cell attachment to fibronectin-coated surfaces or integrin clustering by Abs. p125FAK is also considered a focal adhesion docking protein capable of facilitating the recruitment and activation of other tyrosine-phosphorylated signaling molecules, such as pp60src and paxillin (31, 34, 35). Paxillin is another signaling molecule that localizes to focal adhesions and becomes tyrosine phosphorylated either during integrin-mediated or growth factor-induced adhesion (34, 35). Paxillin contains a domain that interacts with the C-terminus of p125FAK (36), and p125FAK recruitment to focal contacts appears to require paxillin binding (36, 37). Paxillin has been demonstrated to be a substrate for p125FAK phosphorylation in both in vitro (38) and in vivo systems (35, 39). Recently, treatment with several peptide hormones such as prolactin, insulin-like growth factor I (IGF-I), hepatocyte growth factor, vascular endothelial growth factor, and platelet-derived growth factor (PDGF) have been shown to augment the tyrosine phosphorylation of p125FAK (24, 25, 26, 27, 28, 29, 30, 40).

The aim of the present study was to determine how neutrophil adhesive functions are modulated by human pituitary GH. Herein we provide data that pituitary GH treatment potentiates neutrophil adhesion and triggers the tyrosine phosphorylation of Jak2, p125FAK, and paxillin and F-actin formation that may involve in the adhesion signaling of human neutrophils.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Reagents

Human pituitary GH, genistein, and phalloidin-FITC were purchased from Sigma (St. Louis, MO). Protein A-Sepharose, dextran T-500, and Ficoll-Paque were purchased from Pharmacia Biotech (Piscataway, NJ). Anti-phosphotyrosine mAb 4G10 (Upstate Biotechnology, Lake Placid, NY) was used for Western blotting, and anti-phosphotyrosine Ab PY20-agarose conjugate (Santa Cruz Biotechnology, Santa Cruz, CA) was used for immunoprecipitation studies. Rabbit polyclonal anti-Jak2, anti-p125FAK mAb (H-1), and anti-STAT3 Ab were purchased from Santa Cruz Biotechnology. Anti-p125FAK mAb (clone 77) and anti-paxillin mAb was obtained from Upstate Biotechnology and Transduction Laboratories (Lexington, KY), respectively. The enhanced chemiluminescence (ECL) Western blotting system was obtained from Amersham (Arlington Heights, IL). DuPont-New England Nuclear (Boston, MA) was the source of [{gamma}-32P]ATP. Four- and 96-well tissue culture plates and 100- and 35-mm dishes were purchased from Nunc (North Aurora Road, IL). RPMI containing L-arginine (200 mg/L), HBSS, and FBS and other tissue culture reagents were purchased from Life Technologies (Gaithersburg, MD).

PMN isolation

Human venous blood (10 ml) was collected from healthy adult volunteers into heparinized tubes (12). To obtain neutrophils from peripheral blood, the heparinized blood was centrifuged for 10 min at 1000 rpm to remove platelet-rich plasma. After 2% dextran sedimentation of erythrocytes for 30 min, neutrophils were isolated under sterile conditions by density gradient centrifugation on Ficoll-Paque cushions in cornical tubes. The tubes were centrifuged at 2500 rpm for 30 min in swing-out buckets at room temperature. Contaminating erythrocytes were lysed with hypotonic solution containing NH4Cl-EDTA and then washed twice. The cells were gently resuspended in magnesium-free HBSS containing 1.6 mM CaCl2; then the cell number and viability were determined. The entire procedure was conducted in sterile conditions at room temperature. The final cell preparation comprised at least 97% neutrophils and <0.2% monocytes, as assessed by Wright-Giemsa differential staining. The viability of neutrophils was >98% as determined by trypan blue exclusion (12).

Measurement of cell adhesion

Neutrophil adhesion to 96-well tissue culture plate was evaluated as described by Nagata et al. (11). Briefly, nonadherent cells were decanted immediately following the incubation with the reagent, and the reaction wells were rigorously washed three times with 37°C HBSS. A total of 200 µl of 0.5% crystal violet in 12% neutral formaldehyde solution and 10% ethanol were then added to each well for 1 h to fix and stain cells. The samples were thoroughly washed with water and air-dried for 30 min. Crystal violet was extracted by the addition of 1% SDS, and absorbency was measured at 570 nm. Adhesion was expressed as increased absorbency at 570 nm.

Morphological change of neutrophils

Freshly isolated neutrophils were incubated in culture plates or two-well chamber slides for 30 min in the absence or the presence of GH (100 ng/ml). The morphological changes in neutrophils in the culture plate were photographed with a phase contrast objective on a Nikon inverted microscope (x400 magnification). Neutrophil monolayers cultured in two-well chamber slides were rinsed twice with warmed HBSS. Then monolayers were fixed with alcohol and stained with Wright-Giemsa differential staining for 20 min. After washing twice with PBS, monolayers were dried and mounted with Canada balsam. The stained cells were photographed with a bright-field microscope (x400 magnification).

Treatment with reagent and preparation of cytoplasmic extracts

Neutrophils were kept in a serum-free suspension during the course of any treatment. Neutrophil suspensions (1 ml of 1 x 107 cells/ml) were either stimulated with indicated agonists and antagonist or treated with the same volume of the appropriate diluents for the indicated periods of time at 37°C with 5% CO2. Cytoplasmic extracts were prepared essentially as described with some modification (41). Cells were harvested and washed with ice-cold PBS and then resuspended (100 µl/107 cells) in an ice-cold cell extraction buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1 mM PMSF, 10 µg/ml leupeptin, 1 µM pepstatin, 1 mM N-ethylmleimide, 2 mM Na3VO4, 20 mM sodium pyrophosphate, and 50 mM NaF. Lysates were centrifuged at 15,000 rpm at 4°C for 30 min. The clear cytosol was separated from the insoluble pellet fractions and immediately used for immunoprecipitation or Western blot.

Immunoprecipitation and Western blot analysis

Lysates (1 ml) obtained as described above were precleared by the addition of 30 µl of protein A-Sepharose (50% (v/v) slurry) for 1 h at 4°C. Then the precleared lysates were incubated with 5 µg of free Abs for 4–6 h at 4°C on an oscillating platform. Twenty-five microliters of protein A-Sepharose was then added into lysates and left for 1 h at 4°C. In the case of immunoprecipitates of phosphotyrosine (pY), this was followed by the addition of 10 µl of protein A-agarose-conjugated-anti-pY Ab (Santa Cruz Biotechnology) for 4–6 h at 4°C. All beads were collected by centrifugation and were washed twice with modified extraction buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1 mM PMSF, 10 µg/ml leupeptin, 1 µM pepstatin, 1 mM N-ethylmleimide, 2 mM Na3VO4, 20 mM sodium pyrophosphate, and 50 mM NaF and once with PBS. The supernatants were removed carefully, 45 µl of 2x boiling Laemmli’s buffer (1x is 100 mM Tris-HCl (pH 6.8), 4% SDS, 200 mM DTT, 20% glycerol, 2% SDS, 0.2% bromophenol blue, 10 µg/ml aprotinin, and 10 µg/ml leupeptin) was then added. The samples were boiled for 10 min at 100°C and then spun at 15,000 rpm for 10 s. Immunoprecipitates were divided into equal aliquots before separation on the SDS-PAGE as described below. The denatured proteins were electrophoresed on 8% SDS-polyacrylamide gel and transferred to cellulose membrane. Membranes were blocked in 5% skim milk in Tris (pH 7.4), 150 mM NaCl, and 0.05% Tween-20 for 30 min at room temperature. Blots were probed with primary Abs overnight at 4°C. This was followed by incubation with anti-rabbit or anti-mouse IgG conjugated with HRP (Bio-Rad, Richmond, CA) for 2 h. Signals were detected by using the ECL system (Amersham).

Immunofluorescence staining and confocal microscopy

Indirect labeling methods were undertaken to detect the localization of p125FAK, paxillin, and phosphotyrosine in neutrophils. The cellular distribution of F-actin was directly stained using FITC-labeled phalloidin. Adherent cells (4 x 105 cells/ml) were seeded onto two-well chamber slides and incubated for 30 min with serum-free RPMI 1640 medium. Cells were then stimulated with GH (100 ng/ml) for the indicated period of time, and the cell layers were washed twice with PBS and fixed for 15 min with 4% paraformaldehyde (PFA) at room temperature. After washing with PBS, fixed cells were blocked for 1 h with blocking solution containing 0.3% Triton X-100, 5% BSA, and 3% goat serum and then treated with a 1/200 dilution of anti-p125FAK Ab, a 1/200 dilution of anti-paxillin Ab, and a 1/200 dilution of anti-phophotyrosine Ab (4G10) overnight at 4°C. After three washes with PBS, the cells were incubated for 1 h with fluorescence-labeled goat anti-mouse IgG Ab (Vector, Burlingame, CA) diluted 1/200 in PBS. The slides were washed three times with PBS and mounted with fluorochrome mounting solution (Vector), and images were analyzed using a confocal microscope (model LSM 410, Carl Zeiss, Thornwood, NY). The following control experiments showed that staining was specific; no signal was visualized when primary Abs were not added.

In vitro kinase assay

Anti-p125FAK immunoprecipitates were isolated from neutrophil lysates treated with GH for 0–60 min. Immunoprecipitates were washed three times with a lysate buffer and divided into two equal parts. Each part was resuspended in an equal volume (30 µl) of kinase assay buffer (50 mM NaCl, 5 mM MgCl2, 5 mM MnCl2, 0.1 mM Na3VO4, and 10 mM HEPES (pH 7.4) containing [{gamma}-32P]ATP (5 µCi/ml) for 30 min at 37°C. The kinase reaction was stopped by the addition of 5x sample buffer for SDS-PAGE, separated on 8% gel, and visualized by autoradiography. The other part of immunoprecipitates was separated on 8% gel and probed with an anti-p125FAK Ab.

Flow cytometry

For the effect of GH on F-actin formation, we used the method described by Lee et al. (42). Briefly, neutrophils were incubated for 1 h at 37°C with GH (100 ng/ml). Reactions were terminated, and cells were fixed by the addition of 4% PFA for 15 min. Cells were washed twice with PBS, and phalloidin-FITC (100 nM) was added for 5 min. The changes in fluorescence activity were measured using FACStar (Becton Dickinson, Mountain View, CA).

Data analysis

Data are expressed as the mean and SEM. Differences were compared using ANOVA (repeated measures) and the Mann-Whitney test. A significant level was designated at the 95% level (p < 0.05). Statistical calculations were completed using the StatView 512 software package (Abacus Concepts, Berkeley, CA).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Pituitary GH increases neutrophil adhesion

In the first series of experiments the time- and dose-dependent effects of pituitary GH on neutrophil adhesion were determined. The time course for the direct adherence of neutrophils to the plastic substratum of cell cultureware was assessed with or without GH. Maximal adherence of neutrophils was observed at 30 min for both control and GH-treated samples (Table IGo). GH augmented the neutrophil adhesion in a bell-shaped dose-response fashion, with the peak effect observed at 100 ng/ml (Fig. 1GoA). The effect of GH on neutrophil adhesion was modest, and maximally a 32% increase was observed 30 min after GH stimulation. Then we examined the effect of genistein, a typical tyrosine kinase inhibitor, on GH-stimulated neutrophil adhesion. Fig. 1GoB shows that 10 µM genistein decreased the adherence of neutrophils by itself and blocked the effect of pituitary GH. Concentrations ranging from 1 to 10 µM genistein significantly blocked the effect of GH on neutrophil adhesion (data not shown). Photomicrographs of Fig. 1GoC showed that neutrophils in response to GH (100 ng/ml) for 30 min adopted more elongated shapes (Fig. 1GoC, b and d) than control cells, which show a round shape (Fig. 1GoC, a and c). Interestingly, GH-treated neutrophils showed membrane ruffles and exhibited more spreading compared with control neutrophils. The bipolar shape and uropod formation were also observed (Fig. 4Go, C, F, and I). The sustained effect on the shape change by GH was most evident in the distribution of cell adherence by 30 min. These data indicated that the signaling by GH is an effective stimulus for shape change of neutrophils.


View this table:
[in this window]
[in a new window]
  		Table I. Effect of pituitary GH on the neutrophils adhesion1

 


View larger version (34K):
[in this window]
[in a new window]
  		FIGURE 1. Pituitary GH increases the adhesion of human neutrophils. A, Dose-dependent effect of pituitary GH on the adhesion of human neutrophils (n = 8). The neutrophils (4 x 105) were incubated with medium alone or with the indicated concentration of GH for 30 min in a 96-well plate. B, Inhibitory effect of genistein on the GH (100 ng/ml)-stimulated adhesion of neutrophils (n = 6). The cells were preincubated with genistein (10 µM) for 30 min. Values show the change in absorbency at 570 nm. *, Significantly different from the control (no treatment of GH), p < 0.01. {ddagger}, Significantly different from the value of GH-stimulated cells, p < 0.05. C, Morphological changes in neutrophils induced by pituitary GH. Cells were incubated in chamber slides with GH (100 ng/ml) for 30 min and examined by phase contrast light microscopy (a and b). Cells were fixed with 4% paraformaldehyde and stained with Wright-Giemsa solution (c and d). a and c, Medium control; b and d, pituitary GH treatment.

 


View larger version (90K):
[in this window]
[in a new window]
  		FIGURE 4. Focal localization of p125FAK, paxillin, and phosphotyrosine in pituitary GH-stimulated human neutrophils. Neutrophils were treated for 30 min with pituitary GH (100 ng/ml). Cells were then fixed with 4% paraformaldehyde for 15 min and stained for p125FAK (A and B), paxillin (D and E), and phosphotyrosine (G and H) using indirect double immunofluorescence labeling as described in Materials and Methods. C and F, Nomarski views for B and E; I, phase contrast view for H. Scale bar, 5 µm.

 
Pituitary GH stimulates tyrosine phosphorylation of p125FAK and paxillin

Next, the effect of GH stimulation on tyrosine phosphorylation of Jak2, STAT3, p125FAK, and paxillin was examined. Neutrophils were incubated at 37°C with different concentrations of GH (10–500 ng/ml) for 30 min and lysed with detergent. GH induced the tyrosine phosphorylation of Jak2 (Fig. 2GoA), STAT3 (Fig. 2GoB), p125FAK (Fig. 2GoC), and paxillin (Fig. 2GoD) in a bell-shaped, concentration-dependent manner. The half-maximal and maximal increases in the level of tyrosine phosphorylation of Jak2 and STAT3 occurred at 50 and 100 ng/ml, respectively. Furthermore, GH caused a striking increase in the tyrosine phosphorylation of p125FAK and paxillin. The maximal tyrosine phosphorylation of p125FAK and paxillin was observed at 100 ng/ml of GH. Subsequent blotting with respective Abs demonstrated that equal amounts of the protein were loaded in each pair of lanes.



View larger version (39K):
[in this window]
[in a new window]
  		FIGURE 2. Pituitary GH-induced tyrosine phosphorylation of Jak2 (A), STAT3 (B), p125FAK (C), and paxillin (D) in human neutrophils. Cells (4 x 107) were treated with the indicated concentration of GH for 30 min. Cell extracts were immunoprecipitated with anti-Jak2, STAT3, p125FAK, and paxillin Ab, and subsequently blots were probed with anti-PY (4G10) antiserum or anti-Jak2, STAT3, p125FAK, and paxillin Ab as described in Materials and Methods.

 
To examine the kinetics of phosphorylation of Jak2, STAT3, p125FAK, and paxillin, cells were stimulated with GH (100 ng/ml) for 5, 15, 30, and 60 min before lysis. As illustrated in Fig. 3GoA, increased tyrosine phosphorylation of Jak2 was detected 5 min after stimulation, reached its maximum within 15 min, and declined thereafter. The tyrosine phosphorylation of STAT3 (Fig. 3GoB) was also evident after 5 min of stimulation and reached its maximum at 15 min of treatment with GH. After 30 min, the tyrosine phosphorylation of STAT3 was almost reduced. It was noted that GH-stimulated tyrosine phosphorylation of p125FAK and paxillin reached a maximum at 30 min and declined at 60 min. Pretreatment with genistein (10 mM) inhibited the tyrosine phosphorylation of p125FAK (Fig. 3GoC) and paxillin (Fig. 3GoD).



View larger version (37K):
[in this window]
[in a new window]
  		FIGURE 3. Time dependence of pituitary GH-induced tyrosine phosphorylation of Jak2 (A), STAT3 (B), p125FAK (C), and paxillin (D) in human neutrophils. Cells (4 x 107) were treated with GH (100 ng/ml) for the indicated time intervals. Cell extracts were immunoprecipitated with anti-Jak2, STAT3, p125FAK, and paxillin Ab, and subsequently blots were probed with anti-PY (4G10) or anti-Jak2, STAT3, p125FAK, and paxillin Ab as described in Materials and Methods.

 
Localization of p125FAK, paxillin, and phosphotyrosine in pituitary GH-stimulated neutrophils

Previous studies have shown that the initial effect of growth factors such as IGF-I and PDGF is to promote the formation of ruffles and the extension of filopodia or lamellipodia (29, 43, 44). We also tested whether GH could modulate the morphological changes in neutrophils. Our data obtained from confocal microscopy showed that pituitary GH stimulates typical membrane rufflings and uropod formation in neutrophils (Fig. 4Go, C, F, and I). Interestingly, p125FAK and paxillin were localized and concentrated at these focal adhesion sites, such as peripheral rufflings (Fig. 4Go, B and E). These peripheral complexes were clearly distinguished from control cells both morphologically and in the intensity of staining (Fig. 4Go, A and D). Otherwise, pY staining showed the punctate structures in control and GH-stimulated neutrophils (Fig. 4Go, G and H). Although the pY was densely stained in membrane rufflings in the presence of GH (Fig. 4GoH), the distribution of pY showed different patterns from p125FAK and paxillin in neurophils (Fig. 4Go, B and E). In part, these data showed that several proteins other than p125FAK and paxillin are tyrosine phosphorylated upon GH stimulation in neutrophils.

Pituitary GH stimulates the association of p125FAK with Jak2 via STAT3 and in vitro phosphorylation of p125FAK

Although the association between Jak2 and p125FAK has been reported, the possible association mechanism has not been confirmed (45). To investigate the association mechanism of p125FAK with Jak2, neutrophils were treated for 0–60 min with 100 ng/ml pituitary GH. Cells were then lysed, and equally aliquoted lysates were separately immunoprecipitated using anti-Jak2, STAT3, and p125FAK Ab. Western blot analysis, as assessed by coimmunoprecipitation, showed a time-dependent association of p125FAK with Jak2 (Fig. 5GoA). Association between p125FAK and Jak2 was apparent at 15–30 min and diminished 60 min after pituitary GH stimulation. Subsequent immunoblotting with the immunoprecipitating Ab showed the presence of equal amounts of protein. Conversely, we observed the Jak2 and p125FAK association by immunoprecipitation with Jak2 and immunoblotting with p125FAK (Fig. 5GoB). The physical association of Jak2 and p125FAK was enhanced after stimulation with pituitary GH, but there was little constitutive association between these molecules in the controls not treated with pituitary GH. Because it is possible that Jak2 and p125FAK are indirectly linked by another protein and because STAT3 was also shown to be coimmunoprecipitated with Jak2 in neutrophils (Fig. 5GoB), we examined the possibility that STAT3 may mediate the association between Jak2 and p125FAK. Interestingly, as illustrated in Fig. 5Go, C and D, p125FAK was present in the STAT3 immunoprecipitates, and STAT3 was present in the p125FAK immunoprecipitates. The association between STAT3 and p125FAK was also increased after stimulation with pituitary GH.



View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 5. Jak2 associates with p125FAK via STAT3 in vivo in human neutrophils. A, Time dependence of the pituitary GH-stimulated association between p125FAK and Jak2. Neutrophils were treated with GH (100 ng/ml) for the indicated time periods. B, Jak2 association with p125FAK and STAT3 was regulated by pituitary GH. STAT3 was coimmunoprecipitated with p125FAK (C) and vice versa (D). Cell extracts were immunoprecipitated with p125FAK, and subsequently blots were probed with anti-Jak2 Ab as described in Materials and Methods. The same blots were then stripped and reprobed with anti-p125FAK Ab.

 
To determine whether GH signal is involved in the phosphorylation of p125FAK, an in vitro kinase assay was performed using immunoprecipitated p125FAK obtained from the GH-stimulated neutrophils. Fig. 6GoA shows that the autophosphorylation of p125FAK is time dependent. It was shown that the autophosphorylation activity of p125FAK started to increase at 5 min and was maximal at 30 min. Then, the autophosphorylation activity of p125FAK was decreased, but persisted for 60 min (Fig. 6GoA). We further observed that genistein blocked the stimulatory effect of GH on the autophosphorylation of p125FAK (Fig. 6GoB).



View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 6. Pituitary GH increases the autophosphorylation of p125FAK in human neutrophils. A, Time dependence of the autophosphorylation of p125FAK immunoprecipitates by pituitary GH stimulation. Cells (4 x 107) were treated with GH (100 ng/ml) for the indicated time intervals. Cell extracts were immunoprecipitated with anti-p125FAK, and the p125FAK immunoprecipitates were subjected to in vitro kinase assay. B, Inhibitory effect of genistein on the autophosphorylation of p125FAK by pituitary GH stimulation. Cells were preincubated with genistein (10 µM) for 30 min and then treated with GH (100 ng/ml) for 30 min. Anti-p125FAK immunoprecipitates from neutrophil lysates were washed and divided into equal aliquots. The immunoprecipitates of p125FAK were resuspended in the kinase buffer containing [{gamma}-32P]ATP (1 µCi/ml) for 30 min at 37°C. The kinase reactions were stopped by sample buffer for SDS-PAGE. The samples were separated on 8% gel and blotted onto a nitrocellulose membrane, and phosphoproteins were visualized by autoradiography. The other aliquot was used for the determination of protein levels using Western blot analysis. P-p125FAK, phosphorylated p125FAK.

 
GH induces assembly of F-actin in neutrophils

Changes in the organization of the actin cytoskeleton are critical for cell adhesion, membrane rufflings, and uropod extension. We therefore evaluated the potential role of GH on the assembly of microfilament in neutrophils and asked whether GH can modulate the alteration of cytosolic F-actin polymerization in neutrophils by flow cytometry. Our result showed that F-actin levels in neutrophils labeled with phalloidin-FITC was increased by pretreatment with100 ng/ml of pituitary GH for 30 min (Fig. 7GoA). The response of the actin polymerization to GH was clearly distinguishable. As judged by flow cytometric analysis, GH-induced F-actin formation was 72.10 ± 7.11% (n = 3), and the constitutive F-actin formation in the control cells was 53.90 ± 7.29% (n = 3). This shows that pituitary GH modulates the highly compact meshwork of actin filaments found at the leading edge, such as membrane ruffles and uropod of cell (Fig. 7GoB). Through the confocal immunofluorescence data in Fig. 7GoB it was further confirmed that the polymerized F-actin produced by GH stimulation is highly concentrated in the focal adhesion site of neutrophils, as is p125FAK, paxillin, and phosphotyrosine.



View larger version (41K):
[in this window]
[in a new window]
  		FIGURE 7. Stimulatory effect of pituitary GH on F-actin formation in human neutrophils. A, Cells (1 x 106) were incubated with phalloidin-FITC for 30 min after treatment with GH and were fixed with 4% PFA. The fluorescence intensity was measured with FACStar. B, Pituitary GH (100 ng/ml) stimulates the focal localization of F-actin in neutrophils. Cells were stained with phalloidin-FITC and observed under the confocal microscope as described in Materials and Methods. C, The phase contrast view of B. Scale bar, 5 µm.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
It is well established that GH is a physiological mediator of immune cell functions (15, 16, 17, 18, 19), and many of the actions of this stimuli are likely to be transduced through the Jak2 pathway (20, 21, 23). Although it has been reported that GH increases neutrophil adhesion, the possible mechanisms have not been examined (16). The present study demonstrates that pituitary GH stimulates neutrophil adhesion through the modulation of focal adhesion kinase (p125FAK), paxillin, and actin polymerization and further suggests that the neutrophil adhesion pathway by pituitary GH is under Jak2-p125FAK-paxillin tyrosine phosphorylation.

In the present study pituitary GH increased neutrophil adhesion to the plastic substratum. GH also triggered the tyrosine phosphorylation of Jak2 and STAT3 in neutrophils; this is consistent with previous studies of GH-stimulated tyrosine phosphorylation of Jak2 and STATs in the other cell types (20, 21, 22, 23). Our results revealed that the tyrosine phosphorylation of Jak2 occurs about 10–15 min before p125FAK and paxillin tyrosine phosphorylation in neutrophils. There was a >10-min lag between the tyrosine phosphorylation of Jak2 and the p125FAK and paxillin, which indicates those p125FAK and paxillin phosphorylations occur downstream of Jak2. It suggests that GH-stimulated tyrosine phosphorylation of p125FAK and paxillin may occur through the Jak2 signaling event from the GH receptor and subsequently modulate actin polymerization in neutrophils. It is noteworthy to add that a small amount of constitutive tyrosine phosphorylation of Jak2 and p125FAK was observed in neutrophils without any stimulation. In comparison with other experiments, the constitutive tyrosine phosphorylation of Jak2 and p125FAK in our system might be due to the difference in cell types (23, 27, 45). Inhibition of neutrophil adhesion and tyrosine phosphorylation of Jak2, p125FAK, and paxillin by genistein implies that GH-induced neutrophil adhesion is related to the pattern of tyrosine phosphorylation of these signaling molecules. This observation is consistent with a previous report that hepatocyte growth factor-mediated tyrosine phosphorylation of p125FAK is inhibited by the tyrosine kinase inhibitor, herbimycin A, which also blocks spreading and the migratory response of oral squamous carcinoma cells (40).

The earliest and most important events in acute inflammation are the adhesion and emigration of neutrophils from the blood into the tissue. It has been noted that adherent inflammatory cells extended the pseudopodia-like process into underlying endothelial cells (2). To target cells to specific sites, neutrophils should become activated and adhere. Following adhesion, neutrophils undergo cell shape change before they transmigrate across the vessel wall and migrate along a chemotactic gradient (2, 6). The precise mechanism(s) for the adhesion signaling from neutrophil migration to firm adhesion remains largely unknown. Recent results have demonstrated that rGH and prolactin stimulate p125FAK and paxillin tyrosine phosphorylation through the Jak2 pathway (37, 45). In accordance with previous studies, our findings demonstrates that a low dose of pituitary GH (50 ng/ml) induces a striking increase in tyrosine phosphorylation of p125FAK. Also, GH stimulated the tyrosine phosphorylation of paxillin, which is the focal adhesion component and putative p125FAK substrate. Several growth factors have also been reported to increase the tyrosine phosphorylation of paxillin, presumably through the regulation of p125FAK in various kinds of cells (25, 26, 29, 46, 47). Our data showed that the tyrosine phosphorylation of p125FAK and paxillin exhibited a typical bell-shaped dose-response curve, in agreement with the pattern of adhesion and the tyrosine phosphorylation of Jak2. The disruptive effect of pituitary GH at high concentration on the tyrosine phosphorylation of p125FAK and paxillin in neutrophils is similar to the prolacti-n or PDGF-induced tyrosine phosphorylation of p125FAK and paxillin in a breast carcinoma cell line or in Swiss 3T3 cells (25, 27).

The diverse signal transduction pathways of GH stimulation have also been studied in various cell types (15, 16, 45, 48). It was previously been reported that GH promotes association of the p85 subunit of phosphatidylinositol 3-kinase (PI-3 kinase) with insulin receptor substrate-1 and Jak2, and increases enzymatic activity of PI-3 kinase (48, 49). Zhu et al. have recently confirmed that p125FAK is associated with Jak2 after the stimulation of rGH in the CHO cell line (45). Further, it has been shown that the rGH signal can be transmitted to the actin cytoskeleton via Jak, p125FAK, and tensin, and the actin polymerization produced by GH stimulation occurs due to the PI-3 kinase activation (41). Moreover, it has been suggested the indirect association of Jak2 with p125FAK occurs via Tec and PI-3 kinase (41, 50, 51). In the present study we found that the physical association between Jak2 and p125FAK could be mediated via STAT3. This association was significantly increased when neutrophils were treated with pituitary GH, showing that the phosphorylation of Jak2, STAT3, and p125FAK is crucial for the association. Also, the potential interaction of p125FAK at Tyr397 and Tyr925 with molecules containing an SH2 domain such as c-Src and Grb2 suggest that STAT3 may interact with p125FAK through its SH2 domain (52, 53). Interestingly, Pfeffer et al. (54) have determined that STAT3 plays a potential role as one of intracellular adaptor molecules in intracellular signaling (54). They have shown that the type I IFN receptor, IFNAR1, is coupled to PI-3 kinase through STAT3. Thus, the STAT3 molecule can play an adapter function, which couples another signaling molecule to cytokine receptor. Therefore, the possibility that STAT protein may act as an another adapter molecule to couple the growth factor-induced signaling pathway to the adhesion signal through the association with p125FAK can be suggested. However, further study is necessary to elucidate the molecular events responsible for the association between Jak2 and p125FAK via STAT3 in the GH-induced signal transduction pathway.

Previous studies have demonstrated that growth factors, such as insulin, IGF-I, nerve growth factor, and epidermal growth factor, induce rapid membrane ruffling through their respective receptors in a variety of cells (43, 44, 55, 56, 57). Ruffled membrane formation is an alteration in cell morphology and cytoskeletal architecture that can be easily observed under a phase-contrast microscope within a few minutes after adding these growth factors. Therefore, the stimulation of ruffling may be a primary event in the chain of cellular responses triggered by growth factors, eventually leading to cell adhesion and elongation. Furthermore, it is suggested that the membrane ruffles and uropods may effectively mediate cellular adhesion and transmigration of neutrophils (3). However, its exact signaling pathway remains to be clarified. A study recently reported by Leventhal et al. (29) shows that p125FAK and paxillin mediate IGF-I-stimulated lamellaipodial advance and growth cone motility in human neuroblastoma cells. In the present study pituitary GH induces membrane ruffling and uropod formation in human neutrophils. In addition to promoting ruffle formation, we found that GH triggered tyrosine phosphorylation in the region of membrane ruffle. These adhesion foci contained focal concentrations of p125FAK, paxillin, and phosphotyrosine. Interestingly, p125FAK, paxillin, and phosphotyrosine were specifically concentrated in the ruffle and uropodia of neutrophils. Growth factors such as GH, PDGF, IGF-I, and prolactin act through receptors that are catalyzed by intracellular tyrosine kinase (JAKs). These factors show many similarities in their effects on the enhancement of motility and the tyrosine phosphorylation of p125FAK and paxillin (29, 30, 41, 45). Recombinant GH, IGF-I, and PDGF have shown the activation of PI-3 kinase, which modulates direct membrane ruffling (24, 30, 43, 46). Similar to IGF-I and PDGF, our results strongly suggest that p125FAK and paxillin are involved in mediating the biological effects of pituitary GH, which stimulates neutrophil adhesion at least in terms of inducing membrane ruffling and uropod formation.

After the stimulation of cells by agonists, globular actin molecules recruit and polymerize to F-actin, which appears to be the prerequisite for the formation of new pseudopodia and subsequent directed movement (57, 58). According to previous reports, we also proposed that pituitary GH may modulate F-actin formation in the focal adhesion sites in neutrophils. We observed an apparent increase in F-actin level and localization in focal adhesion foci such as membrane ruffles and uropods in neutrophils after GH treatments. The cytoskeleton also plays a key role in growth factor-dependent tyrosine phosphorylation, and may serve to anchor and compartmentalize kinases and other signaling molecules as part of signal transduction complex (29, 59, 60, 61). The integrity of the actin cytoskeleton is essential for the maintenance of p125FAK tyrosine phosphorylation in many cell types (29, 34, 37, 57, 61, 62). Although we have not shown an association of p125FAK and paxillin with the actin cytoskeleton, our results demonstrate that part of the cytoskeleton and adhesion kinases are mainly colocalized in focal adhesion-like sites such as membrane ruffles and uropods when neutrophils are stimulated by pituitary GH.

The present study shows that the relationship between neutrophil adhesion and Jak2, p125FAK, and paxillin tyrosine phosphorylation may be a key aspect of the neutrophil adhesion signaling by pituitary GH. The findings that GH stimulated tyrosine phosphorylation of p125FAK and paxillin and that GH promoted their recruitment to focal adhesions are consistent with a role for these components in GH stimulation of neutrophil adhesion. Our findings have implications for an understanding of the molecular mechanisms that underlie GH-induced neutrophil adhesion. GH, as a classical physiological hormone, could function by an endocrine mechanism to promote the neutrophil adhesion and to regulate the inflammatory process.


   Acknowledgments
 
We thank Dr. Rajiv R. Ratan for help and comments on this study. Drs. Benjamin A. Kruskal and Brian Wilson are greatly appreciated for critical reading of the manuscript, and Vera Zachariassen is appreciated for preparation of the manuscript. Hwa-Jung Huh, Byung-Ki Kim, and Myung-Soo Lee are greatly acknowledged for their fine technical assistance.


   Footnotes
 
1 This work was supported by a postdoctoral fellowship (to H.R.) from the Korean Science and Engineering Foundation and a grant (to H.T.C.) from the Korean Ministry of Education. Back

2 H.R. and J.-H.L. contributed equally to this work. Back

3 Address correspondence and reprint requests to Dr. Hoon Ryu, Department of Neurology, Beth Israel Deaconess Medical Center, Room 847, Harvard Institute of Medicine, 77 Avenue Louis Pasteur, Boston, MA 02115. Back

4 Address correspondence and reprint requests to Dr. Hun-Taeg Chung, Medicinal Resources Research Center and Department of Microbiology and Immunology, Wonkwang University School of Medicine, Iksan, Chonbuk, 570-749, Republic of Korea. Back

5 Abbreviations used in this paper: GH, growth hormone; IGF-I, insulin-like growth factor I; PDGF, platelet-derived growth factor; F-actin, filamentous actin; Jak2, Janus kinase 2; p125FAK, p125 focal adhesion kinase; pY, phosphotyrosine; PFA, paraformaldehyde; PI-3 kinase, phosphatidylinositol 3-kinase. Back

Received for publication December 1, 1999. Accepted for publication May 18, 2000.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Thelen, M., B. Dewald, M. Baggiolini. 1993. Neutrophil signal transduction and activation of the respiratory burst. Physiol. Rev. 73:797.[Free Full Text]
  2. Feng, D., J. A. Nagy, K. Pyne, H. E. Dvorak, A. M. Dvorak. 1998. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J. Exp. Med. 187:903.[Abstract/Free Full Text]
  3. Tsang, Y. T. M., S. Neelamegham, Y. Hu, E. L. Berg, A. R. Burns, C. W. Smith, S. I. Simon. 1997. Synergy between L-selection signaling and chemotactic activation during neutrophil adhesion and transmigration. J. Immunol. 159:4566.[Abstract]
  4. Nick, J. A., N. J. Avdi, S. K. Young, C. Knall, P. Gerwins, G. L. Johnson, G. S. Worthen. 1997. Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J. Clin. Invest. 99:975.[Medline]
  5. Fuortes, M., W. Jin, C. Nathan. 1994. ß2 integrin-dependent tyrosine phosphorylation of paxillin in human neutrophils treated with tumor necrosis factor. J. Cell Biol. 127:1477.[Abstract/Free Full Text]
  6. Werr, J., X. Xie, P. Hedqvist, E. Ruoslahti, L. Lindbom. 1998. ß1 integrins are critically involved in neutrophil locomotion in extravascular tissue in vivo. J. Exp. Med. 187:2091.[Abstract/Free Full Text]
  7. Cai, T., S. D. Wright. 1996. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, {alpha}Mß2) and modulates polymorphonuclear leukocyte adhesion. J. Exp. Med. 184:1213.[Abstract/Free Full Text]
  8. Kindzelskii, A. L., Z. O. Laska, III R. F. Todd, H. R. Petty. 1996. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 ({alpha}Mß2, CD11b/CD18) during neutrophil polarization. J. Immunol. 156:297.[Abstract]
  9. Zhou, M., E. J. Brown. 1993. Leukocyte response integrin and integrin-associated protein act as a signal transduction unit in generation of a phagocyte respiratory burst. J. Exp. Med. 178:1165.[Abstract/Free Full Text]
  10. Hallett, M. B., D. Lloyds. 1995. Neutrophil priming: the cellular signals that say amber but not green. Immunol. Today 16:264.[Medline]
  11. Nagata, M., J. B. Sedgwick, W. W. Busse. 1995. Differential effects of granulocyte-macrophage colony-stimulating factor on eosinophil and neutrophil superoxide anion generation. J. Immunol. 155:4948.[Abstract]
  12. Ryu, H., S. M. Jeong, C. D. Jun, J. H. Lee, J. D. Kim, H. T. Chung. 1997. Involvement of intracellular Ca2+ during growth hormone-induced priming of neutrophils. Brain Behav. Immun. 11:39.[Medline]
  13. Yan, S. R., M. Huang, G. Berton. 1997. Signaling by adhesion in human neutrophils: activation of the p72syk tyrosine kinase and formation of protein complexes containing p72syk and Src family kinases in neutrophils spreading over fibrinogen. J. Immunol. 158:1902.[Abstract]
  14. Argetsinger, L. S., G. S. Campbell, X. Yang, B. A. Witthuhn, O. Silvennoinen, J. N. Ihle, C. Carter-Su. 1993. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74:237.[Medline]
  15. Edwards, III, C. K., S. M. Ghiasuddin, J. M. Schepper, L. M. Yunger, and K. W. Kelley. 1988. A newly defined property of somatotropin: priming of macrophages for production of superoxide anion. Science 239:769.
  16. Fu, Y. K., S. Arkins, B. S. Wang, K.W. Kelley. 1991. A novel role of growth hormone and insulin-like growth factor-I: priming neutrophils for superoxide anion secretion. J. Immunol. 146:1602.[Abstract]
  17. Spadoni, G. L., A. Spagnoli, S. Cianfarani, D. Del Principe, A. Menichelli, S. Di Giulio, B. Boscherini. 1991. Enhancement by growth hormone of phorbol diester-stimulated respiratory burst in human polymorphonuclear leukocytes. Acta Endocrinol. 124:589.
  18. Wiedermann, C. J., M. Niedermuhlbichler, H. Beimpold, H. Braunsteiner. 1991. In vitro activation of neutrophils of the aged by recombinant human growth hormone. J. Infect. Dis. 164:1017.[Medline]
  19. Wiedermann, C. J., M. Niedermuhlbichler, D. Geissler, H. Beimpold, H. Braunsteiner. 1991. Priming of normal human neutrophils by recombinant human growth hormone. Br. J. Haematol. 78:19.[Medline]
  20. Wood, T. J. J., D. Sliva, P. E. Lobie, T. J. Pircher, F. Gouilleux, H. Wakao, J. Gustafsson, B. Groner, G. Norstedt, L. Haldosen. 1995. Mediation of growth hormone-dependent transcriptional activation by mammary gland factor/Stat5. J. Biol. Chem. 270:9448.[Abstract/Free Full Text]
  21. Xu, B. C., X. Wang, C. J. Darus, J. J. Kopchick. 1996. Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor. J. Biol. Chem. 271:19768.[Abstract/Free Full Text]
  22. Han, Y., D. W. Leaman, D. Watling, N. C. Rogers, B. Groner, I. M. Kerr, W. I. Wood, G. R. Stark. 1996. Participation of JAK and STAT proteins in growth hormone-induced signaling. J. Biol. Chem. 271:5947.[Abstract/Free Full Text]
  23. Ram, P. A., D. J. Waxman. 1997. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase. J. Biol. Chem. 272:17694.[Abstract/Free Full Text]
  24. Chen, H., J. Guan. 1994. Stimulation of phosphatidylinositol 3'-kinase association with focal adhesion kinase by platelet-derived growth factor. J. Biol. Chem. 269:31229.[Abstract/Free Full Text]
  25. Ranskin, S., E. Rozengurt. 1994. Platelet-derived growth factor modulation of focal adhesion kinase (p125FAK) and paxillin tyrosine phosphorylation in Swiss 3T3 cells: bell-shaped dose response and cross-talk with bombesin. J. Biol. Chem. 269:704.[Abstract/Free Full Text]
  26. Abedi, H., I. Zachary. 1997. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 272:15442.[Abstract/Free Full Text]
  27. Canbay, E., M. Norman, E. Kilic, V. Goffin, I. Zachary. 1997. Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells. Biochem. J. 324:231.
  28. Fernandez, R., L. A. Boxer, S. J. Suchard. 1997. ß2 integrins are required for tyrosine phosphorylation of paxillin in human neutrophils. J. Immunol. 159:5568.[Abstract]
  29. Leventhal, P. S., E. A. Shelden, B. Kim, E. L. Feldman. 1997. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-I-stimulated lamellipodial advance. J. Biol. Chem. 272:5214.[Abstract/Free Full Text]
  30. Baron, V., V. Calleja, P. Ferrari, F. Alengrin, E. Van Obberghen. 1998. p125FAK focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tyrosine kinase receptors. J. Biol. Chem. 273:7162.[Abstract/Free Full Text]
  31. Schaller, M. D., C. A. Borgman, B. S. Cobb, R. R. Vines, A. B. Reynolds, J. T. Parsons. 1992. pp125FAK, a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc. Natl. Acad. Sci. USA 89:5192.[Abstract/Free Full Text]
  32. Schaller, M. D., J. T. Parsons. 1994. Focal adhesion kinase and associated proteins. Curr. Opin. Cell Biol. 6:705.[Medline]
  33. Richardson, A., J. T. Parsons. 1996. A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature 380:538.[Medline]
  34. Burridge, K., C. E. Turner, L. H. Romer. 1992. Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J. Cell Biol. 119:893.[Abstract/Free Full Text]
  35. Leeb-Lundberg, L. M. F., X. Song, S. A. Mathis. 1994. Focal adhesion-associated proteins p125FAK and paxillin are substrates for bradykinin-stimulated phosphorylation in Swiss 3T3 cells. J. Biol. Chem. 269:24328.[Abstract/Free Full Text]
  36. Tachibana, K., T. Sato, N. D’Avirro, C. Morimoto. 1995. Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J. Exp. Med. 182:1089.[Abstract/Free Full Text]
  37. Nobes, C. D., A. Hall. 1995. Rho, Rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 81:53.[Medline]
  38. Bellis, S. L., J. T. Miller, C. E. Turner. 1995. Characterization of tyrosine phosphorylation of paxillin in vitro by focal adhesion kinase. J. Biol. Chem. 270:17437.[Abstract/Free Full Text]
  39. Schaller, M. D., J. T. Parsons. 1995. pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol. Cell. Biol. 15:2635.[Abstract]
  40. Matsumoto, K., K. Matsumoto, T. Nakamura, R. H. Kramer. 1994. Hepatocyte growth factor/scatter factor induced tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem. 269:31807.[Abstract/Free Full Text]
  41. Goh, E. L. K., T. J. Pircher, T. J. J. Wood, G. Norstedt, R. Galichen, P. E. Lobie. 1997. Growth hormone-induced reorganization of the actin cytoskeleton is not required for STAT5 (signal transducer and activator of transcription-5)-mediated transcription. Endocrinology 138:3207.[Abstract/Free Full Text]
  42. Lee, J. H., H. Ryu, M. K. Han, U. H. Kim, H. T. Chung. 1997. Nitric oxide inhibits capping in HL-60 cells. Biochem. Biophys. Res. Commun. 232:827.[Medline]
  43. Kotani, K., K. Yonezawa, K. Hara, H. Ueda, Y. Kitamura, H. Sakaue, A. Ando, A. Chavanieu, B. Calas, F. Grigorescu, et al 1994. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J. 13:2313.[Medline]
  44. Mellstrom, K., C. Heldin, B. Westermark. 1988. Induction of circular membrane ruffling on human fibroblasts by platelet-derived growth factor. Exp. Cell Res. 177:347.[Medline]
  45. Zhu, T., E. L. K. Goh, P. E. Lobie. 1998. Growth hormone stimulates the tyrosine phosphorylation and association of p125 focal adhesion kinase (FAK) with JAK2. J. Biol. Chem. 273:10682.[Abstract/Free Full Text]
  46. Ranskin, S., R. Hooshmand-Rad, L. Claesson-Welsh, E. Rozengurt. 1996. Requirement for phosphatidylinositol 3'-kinase activity in platelet-derived growth factor-stimulated tyrosine phosphorylation of p125 focal adhesion kinase and paxillin. J. Biol. Chem. 271:7829.[Abstract/Free Full Text]
  47. Brinson, A. E., T. Harding, P. A. Diliberto, Y. He, X. Li, D. Hunter, B. Herman, H. S. Eatp, L. M. Graves. 1998. Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. J. Biol. Chem. 273:1711.[Abstract/Free Full Text]
  48. Ridderstrale, M., E. Degerman, H. Tornqvist. 1995. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J. Biol. Chem. 270:3471.[Abstract/Free Full Text]
  49. VanderKuur, J., G. Allevator, N. Billestrup, G. Norstedt, C. Carter-Su. 1995. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2. J. Biol. Chem. 270:7587.[Abstract/Free Full Text]
  50. Saito, Y., S. Mori, K. Yokote, T. Kanzaki, Y. Saito, N. Morisaki. 1996. Phosphatidylinositol 3-kinase activity is required for the activation of focal adhesion kinase by platelet-derived growth factor. Biochem. Biophys. Res. Commun. 224:23.[Medline]
  51. Takahashi-Tezuka, M., M. Hibi, Y. Fujitani, T. Fukada, T. Yamaguchi, T. Hirano. 1997. Tec tyrosine kinase links the cytokine receptors to PI-3 kinase probably through JAK. Oncogene 14:2273.[Medline]
  52. Schlaepfer, D. D., T. Hunter. 1996. Evidence for in vivo phosphorylation of the Grb2 SH-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol. Cell. Biol. 16:5623.[Abstract]
  53. Schlaepfer, D. D., S. K. Hanks, T. Hunter, P. van der Geer. 1994. Integrin-mediated signal transduction linked to RAS pathway by GRB2 binding to focal adhesion kinase. Nature 372:786.[Medline]
  54. Pfeffer, L. M., J. E. Mullersman, S. R. Pfeffer, A. Murti, W. Shi, C. H. Yang. 1997. STAT3 as an adaptor to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor. Science 276:1418.[Abstract/Free Full Text]
  55. Izumi, T., Y. Saeki, Y. Akanuma, F. Takaro, M. Kasuga. 1988. Requirement for receptor-intrinsic tyrosine kinase activities during ligand-induced membrane ruffling of KB cells. J. Biol. Chem. 263:10386.[Abstract/Free Full Text]
  56. Ridley, A. J., H. F. Paterson, C. L. Johnston, D. Diekmann, A. Hall. 1992. The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling. Cell 70:401.[Medline]
  57. Ridley, A. J., A. Hall. 1992. The small GTP-binding protein Rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389.[Medline]
  58. Lin, C. H., E. M. Espreafico, M. S. Mooseker, P. Forscher. 1996. Myosine drives retrograde F-actin flow in neuronal growth cones. Cell 16:769.
  59. Norgauer, J., I. Just, K. Aktories, L. A. Sklar. 1989. Influence of botulinum C2 toxin on F-actin and N-formyl peptide receptor dynamics in human neutrophils. J. Cell Biol. 109:1133.[Abstract/Free Full Text]
  60. Grimminger, F., U. Sibelius, K. Aktories, I. Just, W. Seeger. 1991. Suppression of cytoskeletal rearrangement in activated human neutrophils by Botulinum C2 toxin. J. Biol. Chem. 266:19276.[Abstract/Free Full Text]
  61. Bretscher, M. S.. 1996. Getting membrane flow and the cytoskeleton to cooperate in moving cells. Cell 87:601.[Medline]
  62. Lawson, M. A., F. R. Maxfield. 1995. Ca2+- and calcineurin-dependent recycling of an integrin to the front of migrating neutrophils. Nature 377:75.[Medline]



This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
M. C. Brown and C. E. Turner
Paxillin: Adapting to Change
Physiol Rev, October 1, 2004; 84(4): 1315 - 1339.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Kira, S. Sano, S. Takagi, K. Yoshikawa, J. Takeda, and S. Itami
STAT3 Deficiency in Keratinocytes Leads to Compromised Cell Migration through Hyperphosphorylation of p130cas
J. Biol. Chem., April 5, 2002; 277(15): 12931 - 12936.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Lavastre, M. Pelletier, R. Saller, K. Hostanska, and D. Girard
Mechanisms Involved in Spontaneous and Viscum album Agglutinin-I-Induced Human Neutrophil Apoptosis: Viscum album Agglutinin-I Accelerates the Loss of Antiapoptotic Mcl-1 Expression and the Degradation of Cytoskeletal Paxillin and Vimentin Proteins Via Caspases
J. Immunol., February 1, 2002; 168(3): 1419 - 1427.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow